Jazz Pharmaceuticals

This study tested an experimental drug called ZW25 for people with advanced bile duct cancers that have a specific genetic feature called HER2 amplification. The trial involved 87 patients whose cancer had progressed after standard chemotherapy. Researchers measured how well the …

This study observed 113 Italian adults with specific aggressive forms of acute myeloid leukemia (AML) who were starting treatment with Vyxeos liposomal in their normal medical care. The goal was to see how well the treatment worked in real-world practice, focusing on achieving de…

This study observed how well the cancer drug Zepzelca works and how safe it is for adults with advanced small cell lung cancer in real-world medical settings. It included 272 patients whose cancer had progressed after initial platinum-based chemotherapy. Researchers tracked treat…

This study tested whether adding an experimental drug called ZW25 to standard chemotherapy could help control advanced stomach, bile duct, and colorectal cancers that have a specific marker called HER2. It involved 74 patients with these cancers that could not be removed by surge…

This study tested whether combining two investigational drugs, zanidatamab and evorpacept, was safe and could help treat people with advanced HER2-expressing cancers that had worsened after standard treatments. The first part of the study focused on finding safe dose levels, and …

This study tested whether a new drug called suvecaltamide could help reduce moderate to severe tremor in people with Parkinson's disease whose shaking is not adequately controlled by their current medications. Over 17 weeks, 169 participants were randomly assigned to receive eith…